GCAND TRAFALGAR INTERNATIONAL, INC. OTC · United States

TRAFALGAR INTERNATIONAL, INC. (GCAND) news GCAND settlement news

Company Updates · Sep 18, 2026

Trafalgar International names Carlos Septién chief executive officer

Porfirio Sanchez Talavera resigned as chief executive officer on September 18, 2026, and Carlos Septién, previously chief operating officer, took the post.

Latest TRAFALGAR INTERNATIONAL, INC. news

Jul 29, 2026Mergers
Trafalgar adds three new officers and three incoming directors
The board of The Greater Cannabis Company, Inc. named Carlos Septién, Michelle Cervantes Vivanco and Ernesto Gómez Berjón on July 29, 2026, and they join the board after a notice period.
Jun 29, 2026Company Updates
Trafalgar Asset Management gains voting control and cancels company debt
Trafalgar Asset Management, LLC bought all the Series A and Series B preferred stock on June 29, 2026, and certain company debts were settled and canceled the same day.

TRAFALGAR INTERNATIONAL, INC. annual financials

Line	FY2025	FY2024
Net income (loss)	-$331,612	-$179,041
Cash from operations	-$60,153	-$109,491

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $111.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about TRAFALGAR INTERNATIONAL, INC.

Has TRAFALGAR INTERNATIONAL, INC. settled a lawsuit?

Our latest story on this, dated Jun 29, 2026: "Trafalgar Asset Management gains voting control and cancels company debt". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of TRAFALGAR INTERNATIONAL, INC.?

TRAFALGAR INTERNATIONAL, INC. trades under the ticker GCAND on OTC.

Where is TRAFALGAR INTERNATIONAL, INC. listed?

TRAFALGAR INTERNATIONAL, INC. is listed on OTC.

Which country or territory is TRAFALGAR INTERNATIONAL, INC. listed under?

Our directory records TRAFALGAR INTERNATIONAL, INC. under United States.

Does aibio.space cover TRAFALGAR INTERNATIONAL, INC.?

aibio.space lists TRAFALGAR INTERNATIONAL, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

Is TRAFALGAR INTERNATIONAL, INC. profitable?

TRAFALGAR INTERNATIONAL, INC. reported a net loss of $331,612 for the fiscal year ended Dec 31, 2025, and used $60,153 of cash in operations, per its annual report to the SEC.

How much cash does TRAFALGAR INTERNATIONAL, INC. have?

$111 in cash at Jun 30, 2026, per its 10-Q.

What is the latest TRAFALGAR INTERNATIONAL, INC. (GCAND) stock news?

Our latest story on TRAFALGAR INTERNATIONAL, INC., dated Sep 18, 2026: "Trafalgar International names Carlos Septién chief executive officer". Porfirio Sanchez Talavera resigned as chief executive officer on September 18, 2026, and Carlos Septién, previously chief operating officer, took the post. Source.

Is TRAFALGAR INTERNATIONAL, INC. being acquired or merging?

Our latest merger story, dated Jul 29, 2026: "Trafalgar adds three new officers and three incoming directors". The board of The Greater Cannabis Company, Inc. named Carlos Septién, Michelle Cervantes Vivanco and Ernesto Gómez Berjón on July 29, 2026, and they join the board after a notice period. Source.

How can I follow TRAFALGAR INTERNATIONAL, INC. (GCAND) news?

Press Follow on this page to add TRAFALGAR INTERNATIONAL, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 3 stories naming TRAFALGAR INTERNATIONAL, INC. so far, in Company Updates, Mergers.

Investor discussion: TRAFALGAR INTERNATIONAL, INC.

Members talk about TRAFALGAR INTERNATIONAL, INC. (GCAND). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:GCAND on TradingView.

Listing details

TRAFALGAR INTERNATIONAL, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker GCAND, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company: TRAFALGAR INTERNATIONAL, INC.
Ticker: GCAND
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction